The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44^hi Stem-Like NSCLC Cells

• Yang Shi,

  Affiliations Department of Pathology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, Department of Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, Texas, United States of America, Cancer Stem Cell Institute, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

  ⨯
• Can Liu,

  Affiliation Department of Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, Texas, United States of America

  ⨯
• Xin Liu,

  Affiliation Department of Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, Texas, United States of America

  ⨯
• Dean G. Tang,

  Affiliations Department of Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, Texas, United States of America, Cancer Stem Cell Institute, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

  ⨯
• Junchen Wang

  * E-mail: jeancwangdfyy@gmail.com

  Affiliations Department of Pathology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, Cancer Stem Cell Institute, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

  ⨯